Literature DB >> 1638247

Giant cell arteritis.

J C Mason, M J Walport.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638247      PMCID: PMC1882633          DOI: 10.1136/bmj.305.6845.68

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  19 in total

1.  Treatment and prognosis in polymyalgia rheumatica and temporal arteritis. A ten-year survey of 53 patients.

Authors:  J von Knorring
Journal:  Acta Med Scand       Date:  1979

2.  Treatment of polymyalgia rheumatica.

Authors:  H Spiera; S Davison
Journal:  Arthritis Rheum       Date:  1982-01

3.  An arteritis with special reference to polymyalgia arteritica.

Authors:  G Ostberg
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1973

4.  The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

Authors:  B A Bengtsson; B E Malmvall
Journal:  Arthritis Rheum       Date:  1981-07

5.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

6.  Polymyalgia rheumatica and corticosteroids: how much for how long?

Authors:  A R Behn; T Perera; A B Myles
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

7.  Prevention of blindness in giant cell arteritis by corticosteroid treatment.

Authors:  A B Myles; T Perera; M G Ridley
Journal:  Br J Rheumatol       Date:  1992-02

8.  Epidemiology of biopsy-proven giant cell arteritis (GCA).

Authors:  E Nordborg; B A Bengtsson
Journal:  J Intern Med       Date:  1990-04       Impact factor: 8.989

9.  Presentation of occult giant cell arteritis.

Authors:  L A Healey; K R Wilske
Journal:  Arthritis Rheum       Date:  1980-06
View more
  3 in total

1.  Surgical performance for specialties undertaking temportal artery biopsies: who should perform them?

Authors:  Gavin D Galloway; Bernhard Klebe; Paul Riordan-Eva
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Giant cell arteritis.

Authors:  V Kyle
Journal:  BMJ       Date:  1992-08-29

3.  Giant cell arteritis.

Authors:  L G Clearkin
Journal:  BMJ       Date:  1992-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.